Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionBanque Cantonale Vaudoise
Latest Disclosed Ownership1,970 shares
Latest Disclosed Value $ 1,522,000
Banque Cantonale Vaudoise reports 69.54% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 20, 2026 - Banque Cantonale Vaudoise filed a 13F-HR form disclosing ownership of 1,970 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $1,522,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 1,162 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 69.54% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,970 808 69.54 1,522 69.68 0.0410
2026-02-06 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,162 -338 -22.53 897 0.0320
2025-11-13 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,500 345 29.87 1 0.0316
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,155 -1,419 -55.13 1 -100.00 0.0247
2025-05-08 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,574 1,757 215.06 2 0.0719
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 817 -621 -43.18 1 -100.00 0.0353
2024-07-31 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,438 -3,225 -69.16 2 -75.00 0.0601
2024-04-10 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,663 1,167 33.38 4 33.33 0.1758
2024-02-07 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,496 -402 -10.31 3 0.00 0.1333
2023-11-08 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,898 310 8.64 3 50.00 0.1602
2023-08-09 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,588 -2,688 -42.83 3 -60.00 0.1202
2023-04-20 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,276 3,670 140.83 5 400.00 0.2530
2023-02-10 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,606 -2,059 -44.14 2 -99.97 0.0984
2022-10-17 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,665 -10 -0.21 3,214 16.32 0.1831
2022-08-02 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,675 1,583 51.20 2,763 27.98 0.1430
2022-05-09 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,092 -2,075 -40.16 2,159 -33.83 0.0930
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,167 1,604 45.02 3,263 51.20 0.1273
2021-10-29 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,563 -219 -5.79 2,158 2.18 0.0928
2021-08-11 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,782 135 3.70 2,112 22.36 0.0939
2021-05-11 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,647 425 13.19 1,726 10.93 0.0876
2021-02-05 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,222 -430 -11.77 1,556 -23.91 0.0862
2020-10-30 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,652 -1,538 -29.63 2,045 -36.80 0.1313
2020-07-22 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,190 2,695 108.02 3,236 165.68 0.2358
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,495 1,243 99.28 1,218 158.60 0.1033
2020-02-10 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,252 1,252 471 0.0322
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.